Nurse Practitioner, Family · Chicago, IL
NPI
1881169571
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6240 W 55th St
Chicago, IL, 60638
Phone (773) 284-2200
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$258K
1,510 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jessica I Rebstock prescribed most often to Medicare patients was Atorvastatin Calcium, with 138 prescriptions and refills. In total Jessica I Rebstock wrote 1,510 Medicare prescriptions that cost $258K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 138 | 369 | 44 | $704 |
| Fluticasone Propionate Generic | 52 | 96 | 22 | $502 |
| Amlodipine Besylate Generic | 51 | 126 | 14 | $295 |
| Jardiance Empagliflozin | 47 | 119 | 14 | $68K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 47 | 47 | 12 | $1,702 |
| Rosuvastatin Calcium Generic | 44 | 123 | 17 | $822 |
| Omeprazole Generic | 38 | 88 | 13 | $282 |
| Lisinopril Generic | 36 | 94 | 13 | $136 |
| Levothyroxine Sodium Generic | 35 | 81 | 12 | $231 |
| Losartan Potassium Generic | 32 | 76 | Under 11 | $198 |
| Diclofenac Sodium Generic | 29 | 33 | 15 | $742 |
| Metformin Hcl Generic | 27 | 77 | 12 | $181 |
| Metformin Hcl Er Metformin Hcl | 26 | 62 | Under 11 | $241 |
| Ozempic Semaglutide | 25 | 36 | Under 11 | $33K |
| Latanoprost Generic | 25 | 25 | Under 11 | $261 |
Brand drugs: 287 claims; generic drugs: 1,188 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jessica I Rebstock were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.